Laxxon is dedicated to revolutionizing the pharmaceutical industry with better, smarter drug delivery solutions for patients.
With our proprietary SPID®-Technology, our additive manufacturing platform is pioneering a new generation of oral medications.
For new and established pharmaceutical drugs, SPID®-Technology unlocks innovative drug delivery advancements paired with fast-tracked market access and extensive IP protection to yield disruptive opportunities in the pharmaceutical space.
Our Commercial Solutions for Pharma
Our Commercial Solutions for Pharma
In the next 10 years, 150+ drugs will come off patent protection. These drugs are worth over $100B in sales.
Laxxon has both an external pipeline and in-house Advanced Patented Generic pipeline.
03.
Pipeline consists of 13 in-house products and 3 products that are being developed for external clients
All products created with our SPID®-Technology manufacturing approach are patent protected,
whether engineered in-house or with an external partner
Our Mission
Laxxon Medical is dedicated to engineering patented 3D pharmaceutical solutions which optimize products and benefit patients.
The basis of Laxxon's pharmaceutical solutions is our cutting-edge 3D screen printing technology and the extensive intellectual property surrounding it.
Our commitment to innovation and health is fueled by the expertise, integrity, agility, and diversity of the Laxxon team.
Laxxon strives to accelerate pharmaceutical progress globally by establishing ourselves as the leader in the field of 3D printed drugs.
